Publications by authors named "Lane Slabaugh"

Claim this Profile
I
Improving health determinants outside of the clinic does not mean outside of clinical science.
Ted Smith, T Joseph Mattingly, Lane Slabaugh

Healthc (Amst)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consumer willingness to pay for pharmacy services: An updated review of the literature.
Jacob T Painter, Laura Gressler, Niranjan Kathe, S Lane Slabaugh, Karen Blumenschein

Res Social Adm Pharm· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Brand and Biosimilar Granulocyte-Colony Stimulating Factors for Prophylaxis of Chemotherapy-Induced Febrile Neutropenia.
Andrea G Douglas, Phil Schwab, Daniel Lane, Kenneth Kennedy, S Lane Slabaugh

J Manag Care Spec Pharm· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A health plan's investigation of Healthy Days and chronic conditions.
Tristan Cordier, S Lane Slabaugh, Eric Havens, Jonathan Pena, Gil Haugh

Am J Manag Care· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbid Arthritis Is Associated With Lower Health-Related Quality of Life in Older Adults With Other Chronic Conditions, United States, 2013-2014.
Eric Havens, S Lane Slabaugh, Charles G Helmick, Tristan Cordier, Matthew Zack

Prev Chronic Dis· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging Health-Related Quality of Life in Population Health Management: The Case for Healthy Days.
S Lane Slabaugh, Mona Shah, Matthew Zack, Laura Happe, Tristan Cordier

Popul Health Manag· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
Vishal Saundankar, Xiaomei Peng, Haoda Fu, Haya Ascher-Svanum, Angel Rodriguez, Lane Slabaugh

J Manag Care Spec Pharm· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
S Lane Slabaugh, Jonathan R Bouchard, Yong Li, Jean C Baltz, Yunus A Meah

Adv Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States.
S Lane Slabaugh, Yihua Xu, Jane N Stacy, Jean C Baltz, Yunus A Meah

Drugs Aging· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial/ethnic and gender differences in severity of diabetes-related complications, health care resource use, and costs in a Medicare population.
Leslie Hazel-Fernandez, Yong Li, Damion Nero, Chad Moretz, Lane Slabaugh

Popul Health Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with increased healthcare costs in Medicare Advantage patients with type 2 diabetes enrolled in a large representative health insurance plan in the US.
S Lane Slabaugh, Bradley H Curtis, Gosia Clore, Haoda Fu, Dara P Schuster

J Med Econ· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidiabetic treatment patterns in a medicare advantage population in the United States.
S Lane Slabaugh, Yihua Xu, Jane N Stacy, Jean C Baltz, Yunus A Meah

Drugs Aging· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of diabetes complications severity to healthcare utilization and costs among Medicare Advantage beneficiaries.
Leslie Hazel-Fernandez, Yong Li, Damion Nero, Chad Moretz, Lane Slabaugh

Am J Manag Care· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: where do we go from here?
Mary S Hayes, Melea A Ward, S Lane Slabaugh, Yihua Xu

Am Health Drug Benefits· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy.
S Lane Slabaugh, Vittorio Maio, Megan Templin, Safiya Abouzaid

Drugs Aging· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis